Taiho Pharmaceutical Licensed To Develop And Sell ABRAXANE Anti-Cancer Agent By American BioScience, Inc.

Published: Nov 21, 2005

Tokyo (JCN) Nov 21, 2005- Taiho Pharmaceutical announced on November 16 that it has signed a licensing agreement with American BioScience for ABRAXANE, an anti-cancer agent. Under the agreement terms, Taiho will develop and sell the agent in Japan.

Back to news